NCT04235556

Integrated Care Pathway in Oncology (PASSION)

Integrated Management of Care Pathway in Oncology. Impact on the Delay of Therapeutic Management and the Satisfaction of Patients and Carers

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,800 (estimated)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...). The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit. The second aim is to assess the satisfaction of patients and health care teams.

Detailed description

PASSION is a french monocentric study. For the retrospective cohort, patient will be selected through the use of data warehouse available on the HEGP. For the prospective cohort, patient will be included according to the selection criteria. Each patient will be followed up during 6 month and a satisfaction questionnaire will be completed at 1 month and 4 month of the first administration of anti-tumor therapy. For both cohort, clinical-anatomo-biological data will be collected through the use of data warehouse available on the HEGP.

Conditions

• Colon Cancer
• Gastric Cancer
• Pancreatic Cancer
• Thoracic Neoplasms
• Breast Cancer
• Ovarian Cancer
• Bladder Cancer
• Prostate Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Care pathway unit	Patients from the prospective cohort will have their health care scheduled by the care pathway unit.

Timeline

• Start date: 2020-02-21
• Primary completion: 2022-12-31
• Completion: 2022-12-31
• First posted: 2020-01-22
• Last updated: 2022-05-13

Locations

1 site across 1 country: France